Cargando…

Cardioprotective Effects of Atorvastatin plus Trimetazidine in Percutaneous Coronary Intervention

Objective: To explore the effects of preoperative administration of conventional doses of atorvastatin plus trimetazidine on the myocardial injury of patients during the perioperative period of percutaneous coronary intervention (PCI). Methodology: 475 cases of acute coronary syndrome patients befor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Xuefeng, Ma, Aiqun, Zhang, Wei, Lu, Qun, Sun, Chaofeng, Tian, Hongyan, Lei, Xinjun, Bai, Xiaojun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Professional Medical Publicaitons 2013
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3809233/ https://www.ncbi.nlm.nih.gov/pubmed/24353574

Ejemplares similares

Effect of Trimetazidine in Patients Undergoing Percutaneous Coronary Intervention: A Meta-Analysis
por: Zhang, Ying, et al.
Publicado: (2015)

The cardioprotective role of trimetazidine on cisplatin-induced cardiotoxicity
por: Küçük, Murathan, et al.
Publicado: (2020)

Role of metabolic manipulator trimetazidine in limiting percutaneous coronary intervention–induced myocardial injury
por: Kazmi, Danish H., et al.
Publicado: (2018)

Assessment of Trimetazidine Treatment in Acute Myocardial Infarction Patients Undergoing Percutaneous Coronary Intervention
por: Tang, Xiuying, et al.
Publicado: (2022)

Predictors of restenosis following percutaneous coronary stent implantation: The role of trimetazidine therapy
por: Csató, Gábor, et al.
Publicado: (2022)

Effects of Trimetazidine Pretreatment on Endothelial Dysfunction and Myocardial Injury in Unstable Angina Patients Undergoing Percutaneous Coronary Intervention
por: Shao, Shuai, et al.
Publicado: (2019)

Cardioprotective Effects of Oral Trimetazidine in Diabetic Patients With Anterior Wall Myocardial Infarction Treated with Thrombolysis
por: Shehata, Mohamed
Publicado: (2014)

Novel sublingual tablets of Atorvastatin calcium/Trimetazidine hydrochloride combination; HPTLC quantification, in vitro formulation and characterization
por: Atia, Noha N., et al.
Publicado: (2019)

The renoprotective effects of simvastatin and atorvastatin in patients with acute coronary syndrome undergoing percutaneous coronary intervention: An observational study
por: Ma, Huan, et al.
Publicado: (2017)

Cardioprotective Effects of Nicorandil on Coronary Heart Disease Patients Undergoing Elective Percutaneous Coronary Intervention
por: Pang, Zhihua, et al.
Publicado: (2017)

High-dose atorvastatin reduces the risk of cardiovascular events in patients with percutaneous coronary intervention
por: Lu, Changqing, et al.
Publicado: (2017)

Cardioprotective effects of single oral dose of nicorandil before selective percutaneous coronary intervention
por: Yang, Jing, et al.
Publicado: (2015)

Treatment effect of metformin combined with atorvastatin in reducing in-stent restenosis after percutaneous coronary intervention in coronary artery disease patients with type 2 diabetic patients
por: Chen, Mingli, et al.
Publicado: (2022)

Effect of trimetazidine on incidence of major adverse cardiac events in coronary artery disease patients undergoing percutaneous coronary intervention: A protocol for systematic review and meta-analysis
por: Zhu, Kun, et al.
Publicado: (2020)

Circular RNA circ_0001006 aggravates cardiac hypertrophy via miR-214-3p/PAK6 axis
por: Lin, Xuefeng, et al.
Publicado: (2022)

Effects of Trimetazidine on T Wave Alternans in Stable Coronary Artery Disease
por: Yaman, Mehmet, et al.
Publicado: (2016)

Admission hyperglycemia and adverse outcomes in diabetic and non-diabetic patients with non-ST-elevation myocardial infarction undergoing percutaneous coronary intervention
por: Hao, Yuanyuan, et al.
Publicado: (2017)

Role of Trimetazidine in Ischemic Preconditioning in Patients With Symptomatic Coronary Artery Disease
por: Costa, Leandro M.A., et al.
Publicado: (2015)

Protection of Ivabradine Combined with Trimetazidine on Myocardial Injury after Percutaneous Coronary Intervention in Patients with Coronary Artery Disease Evaluated by Magnetic Resonance Image under Convolutional Neural Network
por: Chen, Chunhua
Publicado: (2021)

Trimetazidine in Heart Failure
por: Shu, Hongyang, et al.
Publicado: (2021)

Meta-analysis of trimetazidine treatment for cardiomyopathy
por: Fan, Qian, et al.
Publicado: (2018)

High-dose atorvastatin pretreatment could diminishes microvascular impairment in patients undergoing elective percutaneous coronary intervention
por: He, Gui-Xin, et al.
Publicado: (2013)

Simultaneous administration of high-dose atorvastatin and clopidogrel does not interfere with platelet inhibition during percutaneous coronary intervention
por: Kreutz, Rolf P, et al.
Publicado: (2016)

Clinical Efficacy of Trimetazidine and Holistic Management in the Treatment of Coronary Heart Disease
por: QU, Li, et al.
Publicado: (2018)

Acute atorvastatin treatment restores the cardioprotective effects of ischemic postconditioning in hyperlipidemic rats
por: Sun, Tao, et al.
Publicado: (2017)

Effect of MTHFR Gene Polymorphism Impact on Atherosclerosis via Genome-Wide Methylation
por: Lin, Xuefeng, et al.
Publicado: (2016)

Effects of Statins on the Epicardial Fat Thickness in Patients with Coronary Artery Stenosis Underwent Percutaneous Coronary Intervention: Comparison of Atorvastatin with Simvastatin/Ezetimibe
por: Park, Jae-Hyeong, et al.
Publicado: (2010)

Does Pre-Treatment with High Dose Atorvastatin Prevent Microvascular Dysfunction after Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome?
por: Lee, Bong-Ki, et al.
Publicado: (2016)

Comparison between rosuvastatin and atorvastatin for the prevention of contrast-induced nephropathy in patients with STEMI undergoing primary percutaneous coronary intervention
por: Firouzi, Ata, et al.
Publicado: (2018)

Effect of loading dose of atorvastatin therapy prior to percutaneous coronary intervention in patients with acute coronary syndrome: a meta-analysis of six randomized controlled trials
por: Ma, Mingfeng, et al.
Publicado: (2019)

The Impact of Trimetazidine Treatment on Left Ventricular Functions and Plasma Brain Natriuretic Peptide Levels in Patients with Non-ST Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention
por: Demirelli, Selami, et al.
Publicado: (2013)

Effect of trimetazidine on heart rate variability in elderly patients with acute coronary syndrome
por: Zhang, Jing, et al.
Publicado: (2016)

Comparing Trimetazidine with Allopurinol in Prevention of Contrast Induced Nephropathy After Coronary Angiography
por: Galal, Haitham, et al.
Publicado: (2020)

Comparison of the Treatment Efficacy of Rosuvastatin versus Atorvastatin Loading Prior to Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction
por: Adel, Esraa M., et al.
Publicado: (2022)

Effectiveness of Proanthocyanidin plus Trimetazidine in the Treatment of Non-Small-Cell Lung Cancer with Radiation Heart Injury
por: Yin, Hang, et al.
Publicado: (2022)

Long-term benefits of high-intensity atorvastatin therapy in Chinese acute coronary syndrome patients undergoing percutaneous coronary intervention: A retrospective study
por: Liu, Hui, et al.
Publicado: (2018)

Cardiac Effects of Trimetazidine in Diabetic Rats
por: Mansur, Alfredo J.
Publicado: (2019)

Clinical effects of carvedilol and trimetazidine for the treatmentof alcoholic myocardiopathy
por: Li, Hui, et al.
Publicado: (2016)

The Comparison of Long-Term Outcome Between Patients with Single and Multiple Coronary Chronic Total Occlusions After Percutaneous Coronary Intervention
por: Cao, Miaomiao, et al.
Publicado: (2022)

Cardioprotective effect of acupuncture for percutaneous coronary intervention-related myocardial injury in patients with coronary artery disease: A protocol for systematic review and meta-analysis
por: Chen, Cong, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_84li2tq3qc35m6s1c1oqbh1f43